Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

842 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Implications of NADPH oxidase 5 in vascular diseases.
Marqués J, Cortés A, Pejenaute Á, Zalba G. Marqués J, et al. Among authors: cortes a. Int J Biochem Cell Biol. 2020 Nov;128:105851. doi: 10.1016/j.biocel.2020.105851. Epub 2020 Sep 16. Int J Biochem Cell Biol. 2020. PMID: 32949687 Review.
NADPH Oxidase 5 (NOX5) Overexpression Promotes Endothelial Dysfunction via Cell Apoptosis, Migration, and Metabolic Alterations in Human Brain Microvascular Endothelial Cells (hCMEC/D3).
Marqués J, Fernández-Irigoyen J, Ainzúa E, Martínez-Azcona M, Cortés A, Roncal C, Orbe J, Santamaría E, Zalba G. Marqués J, et al. Among authors: cortes a. Antioxidants (Basel). 2022 Oct 29;11(11):2147. doi: 10.3390/antiox11112147. Antioxidants (Basel). 2022. PMID: 36358519 Free PMC article.
Neuropathological stage-dependent proteome mapping of the olfactory tract in Alzheimer's disease: From early olfactory-related omics signatures to computational repurposing of drug candidates.
Cartas-Cejudo P, Cortés A, Lachén-Montes M, Anaya-Cubero E, Puerta E, Solas M, Fernández-Irigoyen J, Santamaría E. Cartas-Cejudo P, et al. Among authors: cortes a. Brain Pathol. 2024 Mar 7:e13252. doi: 10.1111/bpa.13252. Online ahead of print. Brain Pathol. 2024. PMID: 38454090
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04 (PANGEA-Breast) study.
de la Cruz-Merino L, Gion M, Cruz J, Alonso-Romero JL, Quiroga V, Moreno F, Andrés R, Santisteban M, Ramos M, Holgado E, Cortés J, López-Miranda E, Cortés A, Henao F, Palazón-Carrión N, Rodriguez LM, Ceballos I, Soto A, Puertes A, Casas M, Benito S, Chiesa M, Bezares S, Caballero R, Jiménez-Cortegana C, Sánchez-Margalet V, Rojo F. de la Cruz-Merino L, et al. Among authors: cortes j, cortes a. BMC Cancer. 2022 Dec 3;22(1):1258. doi: 10.1186/s12885-022-10363-3. BMC Cancer. 2022. PMID: 36463104 Free PMC article. Clinical Trial.
842 results